GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Actuate Therapeutics

ACTU 0.61 -10.13%

Close of 9 October 2026, in USD — never converted.

Actuate Therapeutics — daily ACTU Delayed

Chart and prices are provided by TradingView. Global Banking & Finance Review publishes no price data on this page. Nothing here is investment advice. How we cover markets.

Frequently asked questions

What is Actuate Therapeutics's ticker?

Actuate Therapeutics trades as ACTU on its US listing, under ISIN US0050831009.

What was Actuate Therapeutics's last closing price?

0.61 on 9 October 2026. The figure is in USD and is never converted.

Does Global Banking & Finance Review publish price data for Actuate Therapeutics?

We publish the closing prices we record ourselves, in the currency the instrument trades in. Charts and live quotes come from TradingView. Nothing on this page is investment advice.